|Articles|March 10, 2011

Oncology Nursing News

  • February 2011
  • Volume 5
  • Issue 1

Do Breast Implants Increase Cancer Risk?

The FDA is examining a potential link between breast implants and anaplastic large cell lymphoma (ALCL), a rare and aggressive form of non-Hodgkin lymphoma.

The FDA is examining a potential link between breast implants and anaplastic large cell lymphoma (ALCL), a rare and aggressive form of non-Hodgkin lymphoma. Federal health officials believe the implants might increase a woman’s risk of developing ALCL in the scar tissue next to the implant. The FDA’s findings are based on a review of scientific literature dating back to 1997, which includes 60 cases of ALCL in women with breast implants. Thus far, the FDA has been unable to identify a type of implant or reason for implant that may increase a woman’s risk. To facilitate its investigation, the FDA is creating a registry with the help of the American Society of Plastic Surgeons and other expert groups.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.


Latest CME